COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2003: Articles 20021-20030  | Next

Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, France
Bal, A., Destras, G., Gaymard, A., Regue, H., Semanas, Q., d'Aubarde, C., Billaud, G., Laurent, F., Gonzales, C., Valette, M., Lina, B., Morfin, F., Josset, L.
10.1101/2020.11.10.20228528 — Posted: 2020-11-13
Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients
Abdulrahman, A., Mustafa, F., AlAwadhi, A. I., Alansari, Q., AlAlawi, B., AlQahtani, M.
10.1101/2020.11.10.20228973 — Posted: 2020-11-13
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among Hospital Workers - a multicentre cross-sectional study
Kahlert, C. R., Persi, R., Guesewell, S., Egger, T., Leal-Neto, O. B., Sumer, J., Flury, D., Brucher, A., Lemmenmeier, E., Moeller, C., Rieder, P., Stocker, R., Vuichard-Gysin, D., Wiggli, B., Albrich, W. C., Babouee Flury, B., Besold, U., Fehr, J., Kuster, S. P., McGeer, A., Risch, L., Schlegel, M., Vernazza, P., Friedl, A., Kohler, P.
10.1101/2020.11.10.20229005 — Posted: 2020-11-13
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Meoni, G., Ghini, V., Maggi, L., Vignoli, A., Mazzoni, A., Salvati, L., Capone, M., Vanni, A., Tenori, L., Fontanari, P., Lavorini, F., Peris, A., Bartoloni, A., Liotta, F., Cosmi, L., Luchinat, C., Annunziato, F., Turano, P.
10.1101/2020.11.10.20228361 — Posted: 2020-11-13
SARS-CoV-2 antibody signatures for predicting the outcome of COVID-19
Fan, X., Lei, Q.
10.1101/2020.11.10.20228890 — Posted: 2020-11-13
Care homes, their communities, and resilience in the face of the COVID-19 pandemic: interim findings from a qualitative study
Marshall, F., Gordon, A. L., Gladman, J. R., Bishop, S.
10.1101/2020.11.10.20229013 — Posted: 2020-11-13
A functional genomics approach to understand host genetic regulation ofCOVID-19 severity
Kuijpers, Y., Chu, X., Jaeger, M., Moorlag, S., Koeken, V., Mourits, V., J. de Bree, L. C., De Mast, Q., van de Veerdonk, F., Joosten, L., Li, Y., Netea, M., Xu, C.-J.
10.1101/2020.11.10.20229203 — Posted: 2020-11-13
Subjective mental health and need for care among psychiatric outpatients during the COVID-19 pandemic: results from an outreach initiative in Sweden
Flygare, O., Ivanov, V. Z., Sall, R., Malaise, H., Ruck, C., Jayaram-Lindstrom, N., Martinsson, L.
10.1101/2020.11.10.20229039 — Posted: 2020-11-13
Parents' Likelihood to Vaccinate Their Children and Themselves Against COVID-19
Davis, M. M., Zickafoose, J. S., Halvorson, A. E., Patrick, S.
10.1101/2020.11.10.20228759 — Posted: 2020-11-13
A retrospective cluster analysis of COVID-19 cases by county
Megahed, F. M., Jones-Farmer, L. A., Rigdon, S. E.
10.1101/2020.11.12.379537 — Posted: 2020-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).